About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
PhRMA’s submission to the U.S. Trade Representative (USTR) for inclusion in the 2021 National Trade Estimate (NTE) Report outlines the principal trade barriers biopharmaceutical companies face worldwide and identifies concrete actions the U.S. government can take to address these obstacles. Recognizing the unprecedented scale of the COVID-19 pandemic and the significant impact that it is having on global health and economies, it is essential that governments and industry continue working together to provide access to safe and effective COVID-19 treatments and vaccines once approved.
PhRMA Comments to the 2021 National Trade Estimate Report image
Report
International
PhRMA Comments to the 2021 National Trade Estimate Report
PhRMA Comments to the 2021 National Trade Estimate Report image